Daniel Clark
Stock Analyst at Leerink Partners
(3.40)
# 2,395
Out of 4,835 analysts
48
Total ratings
58.8%
Success rate
14.7%
Average return
Main Sectors:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals | Initiated Coverage: Buy | $23 | $17.01 | +35.21% | 1 | Sep 9, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $104 | $71.18 | +46.11% | 1 | Sep 9, 2026 | |
| BLCO Bausch + Lomb | Initiated Coverage: Buy | $24 | $17.35 | +38.33% | 1 | Sep 9, 2026 | |
| COLL Collegium Pharmaceutical | Initiated Coverage: Buy | $45 | $22.75 | +97.80% | 1 | Sep 9, 2026 | |
| HROW Harrow | Initiated Coverage: Buy | $45 | $34.48 | +30.51% | 1 | Sep 9, 2026 | |
| PCRX Pacira BioSciences | Initiated Coverage: Hold | $28 | $25.22 | +11.05% | 1 | Sep 9, 2026 | |
| PHAT Phathom Pharmaceuticals | Initiated Coverage: Hold | $10 | $8.36 | +19.62% | 1 | Sep 9, 2026 | |
| TEVA Teva Pharmaceutical Industries | Initiated Coverage: Buy | $45 | $37.09 | +21.33% | 1 | Sep 9, 2026 | |
| VTRS Viatris | Initiated Coverage: Buy | $20 | $16.51 | +21.14% | 1 | Sep 9, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | $24 → $30 | $23.17 | +29.48% | 14 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $745 → $785 | $504.70 | +55.54% | 13 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $153 → $152 | $72.97 | +108.30% | 12 | Oct 13, 2025 |
Amneal Pharmaceuticals
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $17.01
Upside: +35.21%
ANI Pharmaceuticals
Sep 9, 2026
Reiterated: Buy
Price Target: $104
Current: $71.18
Upside: +46.11%
Bausch + Lomb
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $17.35
Upside: +38.33%
Collegium Pharmaceutical
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $22.75
Upside: +97.80%
Harrow
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $34.48
Upside: +30.51%
Pacira BioSciences
Sep 9, 2026
Initiated Coverage: Hold
Price Target: $28
Current: $25.22
Upside: +11.05%
Phathom Pharmaceuticals
Sep 9, 2026
Initiated Coverage: Hold
Price Target: $10
Current: $8.36
Upside: +19.62%
Teva Pharmaceutical Industries
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $37.09
Upside: +21.33%
Viatris
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $16.51
Upside: +21.14%
Elanco Animal Health
Feb 24, 2026
Reiterated: Buy
Price Target: $24 → $30
Current: $23.17
Upside: +29.48%
Nov 3, 2025
Reiterated: Buy
Price Target: $745 → $785
Current: $504.70
Upside: +55.54%
Oct 13, 2025
Reiterated: Hold
Price Target: $153 → $152
Current: $72.97
Upside: +108.30%